Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: Differential effects according to serotype and immune status

Journal of Infectious Diseases

Volumn 203, Issue 9, 2011, Pages 1292-1300

  Duyen, Huynh T L ^a   Ngoc, Tran V ^b,c   Ha, Do T ^c   Hang, Vu T T ^a   Kieu, Nguyen T T ^a   Young, Paul R ^d   Farrar, Jeremy J ^a,e   Simmons, Cameron P ^a,e   Wolbers, Marcel ^a,e   Wills, Bridget A ^a,e  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Medical Clinic   (Viet Nam)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 1;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DISEASE COURSE; FEMALE; HEMOCONCENTRATION; HUMAN; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SECONDARY INFECTION; SEROTYPE; THROMBOCYTOPENIA; VIREMIA; VIRUS LOAD;

EID: 79954627419     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir014     Document Type: Article

References (33)

1. WHO. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization, 2009.
2. Pediatric Dengue Vaccine Initiative, 2009. Global burden of dengue. http://www.pdvi.org/about-dengue/GBD.asp. Accessed 20 July 2010.
3. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006;19:429-36. (Pubitemid 44338101)
4. Kliks S, Nimmanitya S, Nisalak A, Burke D. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988;38:411-9. (Pubitemid 18086128)
5. Chau TN, Anders KL, Lien le B, et al. Clinical and virological features of Dengue in Vietnamese infants. PLoS Negl Trop Dis 2010;4:e657.
6. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984;120:653-69. (Pubitemid 15210730)
7. Halstead SB. Dengue. Lancet 2007;370:1644-52. (Pubitemid 350052290)
8. Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 1970;42:311-28.
9. Halstead SB, O'Rourke EJ. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977;265:739-41. (Pubitemid 8039460)
10. Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010;328:745-8.
11. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003;9:921-7. (Pubitemid 36889936)
12. Kuberski T, Rosen L, Reed D, Mataika J. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. Am J Trop Med Hyg 1977;26:775-83. (Pubitemid 8169300)
13. Gubler DJ, Reed D, Rosen L, Hitchcock JR Jr. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg 1978;27:581-9. (Pubitemid 8367657)
14. Gubler DJ, Suharyono W, Lubis I, Eram S, Sulianti Saroso J. Epidemic dengue hemorrhagic fever in rural Indonesia. I. Virological and epidemiological studies. Am J Trop Med Hyg 1979;28:701-10. (Pubitemid 9233206)
15. Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A. Viraemia in patients with naturally acquired dengue infection. Bull World Health Organ 1981;59:623-30. (Pubitemid 12013485)
16. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9. (Pubitemid 30049026)
17. Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002;185:1213-21. (Pubitemid 34439127)
18. Guilarde AO, Turchi MD, Siqueira JB Jr., et al. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis 2008;197:817-24. (Pubitemid 351417004)
19. Harris E, Videa E, Perez L, et al. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 2000;63:5-11. (Pubitemid 32423088)
20. Murgue B, Roche C, Chungue E, Deparis X. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 2000;60:432-8. (Pubitemid 30127315)
21. Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000;38:1053-7. (Pubitemid 30140558)
22. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002;40:376-81. (Pubitemid 34130856)
23. Libraty DH, Young PR, Pickering D, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002;186:1165-8. (Pubitemid 35177121)
24. Hang VT, Nguyet NM, Trung DT, et al. Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses. PLoS Negl Trop Dis 2009;3:e360.
25. Tricou V, Vu HT, Quynh NV, et al. Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect Dis 2010;10:142.
26. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997;176:322-30. (Pubitemid 27328753)
27. Cardosa M, Wang S, Sum M, Tio P. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol 2002;2:9.
28. Shu PY, Chang SF, Kuo YC, et al. Development of group-and serotypespecific one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue virus. J Clin Microbiol 2003;41:2408-16.
29. Simmons CP, Popper S, Dolocek C, et al. Patterns of host genomewide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 2007;195:1097-107. (Pubitemid 46543440)
30. Gelman A, Jakulin J, Pittau MG, Su YS. A weakly informative default prior distribution for logistic and other regression models. Ann Appl Stat 2008;2:1360-83.
31. Hothorn T, Bretz F, Westfall P. Simultaneous inference in general parametric models. Biom J 2008;50:346-63.
32. R Development Core Team. R: A Language and Environment for Statistical Computing. http://www.r-project.org. Accessed 25 July 2010.
33. Ty Hang VT, Holmes EC, Veasna D, et al. Emergence of the asian 1 genotype of dengue virus serotype 2 in Vietnam: in vivo fitness advantage and lineage replacement in South-East Asia. PLoS Negl Trop Dis 2010;4:e757.